Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics

TS Shippenberg and C Heidbreder

Behavioral Pharmacology and Genetics Section, Addiction Research Center/NIDA, Baltimore, Maryland, USA.

An unbiased place preference conditioning procedure was used to determine whether the repeated administration of cocaine results in sensitization to its conditioned rewarding effects. Rats received noncontingent injections of saline or cocaine (10 mg/kg i.p.) for 5 days. Place preference conditioning commenced 72 hr later. A minimum of three drug conditioning sessions was necessary for the establishment of cocaine-induced conditioned place preferences (CPP) in saline- pretreated rats. The minimum dose producing this effect was 10.0 mg/kg. In contrast, pre-exposure to cocaine resulted in significant place preferences occurring after only two drug conditioning sessions. Furthermore, CPP was observed in response to doses as low as 5.0 mg/kg. This shift in the cocaine dose-response curve was apparent when conditioning commenced either 3 or 7, but not 14, days after the cessation of cocaine pretreatment. An increased sensitivity to cocaine was also observed in rats which received only two cocaine (25.0 mg/kg) injections before conditioning and in those which had received either d- amphetamine (0.5 mg/kg) or morphine (5.0 mg/kg) for 5 days. Repeated administration of the D1 dopamine (DA) receptor antagonist, SCH-23390 (0.01-0.05 mg/kg), or the D2 antagonist, raclopride (0.1-1.0 mg/kg), for 5 days did not modify cocaine-induced place conditioning. Administration of SCH-23390 (0.05 mg/kg) in combination with cocaine, however, prevented the sensitized response to cocaine. In contrast, raclopride did not influence the sensitized response to cocaine. These data demonstrate that sensitization occurs to the conditioned rewarding effects of cocaine and suggest an involvement of D1 DA receptors in the development of this phenomenon.

Volume 273, Issue 2, pp. 808-815, 05/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. R. Taylor, W. J. Lynch, H. Sanchez, P. Olausson, E. J. Nestler, and J. A. Bibb Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine PNAS, March 6, 2007; 104(10): 4147 - 4152. [Abstract] [Full Text] [PDF]

				J. McDaid, J. E. Dallimore, A. R. Mackie, A. L. Mickiewicz, and T. C. Napier Cross-Sensitization to Morphine in Cocaine-Sensitized Rats: Behavioral Assessments Correlate with Enhanced Responding of Ventral Pallidal Neurons to Morphine and Glutamate, with Diminished Effects of GABA J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1182 - 1193. [Abstract] [Full Text] [PDF]

				Y. Dong, D. Saal, M. Thomas, R. Faust, A. Bonci, T. Robinson, and R. C. Malenka Cocaine-induced potentiation of synaptic strength in dopamine neurons: Behavioral correlates in GluRA(-/-) mice PNAS, September 28, 2004; 101(39): 14282 - 14287. [Abstract] [Full Text] [PDF]

				J. A. Kim, K. A. Pollak, G. O. Hjelmstad, and H. L. Fields A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism PNAS, April 13, 2004; 101(15): 5664 - 5669. [Abstract] [Full Text] [PDF]

				P. Vezina, D. S. Lorrain, G. M. Arnold, J. D. Austin, and N. Suto Sensitization of Midbrain Dopamine Neuron Reactivity Promotes the Pursuit of Amphetamine J. Neurosci., June 1, 2002; 22(11): 4654 - 4662. [Abstract] [Full Text] [PDF]

				C. L. Walters and J. A. Blendy Different Requirements for cAMP Response Element Binding Protein in Positive and Negative Reinforcing Properties of Drugs of Abuse J. Neurosci., December 1, 2001; 21(23): 9438 - 9444. [Abstract] [Full Text] [PDF]

				C. L. Wyvell and K. C. Berridge Incentive Sensitization by Previous Amphetamine Exposure: Increased Cue-Triggered "Wanting" for Sucrose Reward J. Neurosci., October 1, 2001; 21(19): 7831 - 7840. [Abstract] [Full Text] [PDF]

				E. Meririnne, A. Kankaanpaa, and T. Seppala Rewarding Properties of Methylphenidate: Sensitization by Prior Exposure to the Drug and Effects of Dopamine D1- and D2-Receptor Antagonists J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 539 - 550. [Abstract] [Full Text] [PDF]

				A. C. Thompson, A. Zapata, J. B. Justice Jr, R. A. Vaughan, L. G. Sharpe, and T. S. Shippenberg {kappa}-Opioid Receptor Activation Modifies Dopamine Uptake in the Nucleus Accumbens and Opposes the Effects of Cocaine J. Neurosci., December 15, 2000; 20(24): 9333 - 9340. [Abstract] [Full Text] [PDF]

				J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine Pharmacol. Rev., June 1, 1999; 51(2): 341 - 396. [Abstract] [Full Text] [PDF]

				G. Le Pen, D. Duterte-Boucher, and J. Costentin Sensitization to the Rewarding Effects of the Specific Dopamine Uptake Inhibitor GBR12783 J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 688 - 696. [Abstract] [Full Text]